Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® ...

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...

VRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years ...

Vertex Pharmaceuticals (VRTX) on Tuesday announced that the European Commission has granted approval for Alyftrek for the ...

Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...

While most of us are familiar with type 1, type 2, and even gestational diabetes, there are actually six kinds of diabetes ...

Ben is running 12 marathons in 12 months to raise awareness for cystic fibrosis, a condition he's battled since childhood.

Vertex Pharmaceuticals today announced that the European Commission has granted approval for Alyftrek ...

Doctors and patients have urged the NSW health minister to intervene in the latest mass resignation to hit the state’s public ...

Thousands of women with advanced breast cancer could be denied life-extending drugs because of the “unfair” way they are ...